VERSARIEN PLC

Report Publication Announcement • Jan 24, 2023

National Storage Mechanism | Additional information

RNS Number : 7266N

Versarien PLC

24 January 2023

24 January 2023

Versarien Plc

("Versarien", the "Company" or the "Group")

Final Results Update

Versarien Plc (AIM: VRS), the advanced engineering materials group, announces that, further to the notification of 24 February 2022, the Company will now announce its audited final results for the 18-month period ended 30 September 2022 by 23 February 2023.

For further information please contact:

Versarien Plc
Neill Ricketts - Chief Executive Officer	+44 (0) 1594 887204
Chris Leigh - Chief Financial Officer
Dr Stephen Hodge - Chief Technology Officer
SP Angel Corporate Finance (Nominated Adviser and Joint Broker)
Matthew Johnson Adam Cowl	+44 (0) 20 3470 0470
Berenberg (Joint Broker)
Mark Whitmore Ciaran Walsh	+44 (0) 20 3207 7800
IFC Advisory Limited (Financial PR & Investor Relations)
Tim Metcalfe Zach Cohen	+44 (0) 20 3934 6630

Notes to Editors:

The strategy of Versarien Plc (AIM:VRS) is to be a globally recognised graphene company with a wide portfolio of high-quality verified materials allied to the largest relevant IP portfolio supported by its own UK based research and development centre driving recurring revenue growth through its innovative graphene product applications.

For further information please see: http://www.versarien.com  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NORFLFEVLVISFIV